Presentation TCT 2025 The APTURE Transcatheter Shunt: Technology Demonstration and Rationale of the ALT FLOW II Trial 8:23 AM – 8:30 AM PDT Presenter: Dean J. Kereiakes October 28, 2025
Presentation TCT 2024 Welcome, Clinical Rationale of Bioadaptive PCI Presenter: Dean Kereiakes October 30, 2024
Presentation TCT 2024 The Weight of a Lifetime of Lead: My Personal Journey Through Radiation Exposure Presenter: Dean Kereiakes October 28, 2024
Presentation TCT 2020 OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES Presenter: Dean Kereiakes October 17, 2020
Presentation TCT 2020 OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier Presenter: Dean J. Kereiakes October 17, 2020
Presentation TCT 2020 Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study Presenter: Dean J. Kereiakes October 15, 2020
Presentation TCT 2018 ABSORB Beyond 3 Years: ABSORB III 4-Year Data Presenter: Bernard R. Chevalier, Stephen G. Ellis, Dean J. Kereiakes September 22, 2018
Presentation TCT 2018 TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes September 21, 2018
Presentation TCT 2017 ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes? Presenter: Azeem Latib, Dean J. Kereiakes October 31, 2017
Presentation TCT 2017 Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes October 30, 2017
Presentation TCT 2017 Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein October 30, 2017
Presentation TCT 2017 Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It? Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran October 30, 2017
Presentation TCT 2017 Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith October 30, 2017
Presentation TCT 2017 Impact of Mandatory Stent Price Controls 1: Physician Perspectives Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul October 30, 2017
Presentation TCT 2017 Impact of AUC and Public Reporting: Is PCI Now More Appropriate? Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher October 30, 2017
Presentation TCT 2017 Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development? Presenter: Dean J. Kereiakes, Spencer B. King III, Elazer R. Edelman October 30, 2017
Presentation TCT 2017 New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us? Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn October 30, 2017
Presentation TCT 2017 Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber October 30, 2017
Presentation TCT 2017 Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go Presenter: Dean J. Kereiakes, Spencer B. King III, Robert A. Byrne October 30, 2017
Presentation TCT 2016 BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and Case Examples) Presenter: Dean J. Kereiakes, Robert-Jan van Geuns, Wojtek Wojakowski November 01, 2016